SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009820
Filing Date
2016-11-09
Accepted
2016-11-09 16:08:41
Documents
51
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20160930x10q.htm 10-Q 1846185
2 EX-10.1 edit-20160930ex101ffd68a.htm EX-10.1 362334
3 EX-31.1 edit-20160930ex311754cd6.htm EX-31.1 18633
4 EX-31.2 edit-20160930ex312792895.htm EX-31.2 18210
5 EX-32.1 edit-20160930ex32165e32f.htm EX-32.1 13602
  Complete submission text file 0001558370-16-009820.txt   6235692

Data Files

Seq Description Document Type Size
6 EX-101.INS edit-20160930.xml EX-101.INS 1090578
7 EX-101.SCH edit-20160930.xsd EX-101.SCH 44620
8 EX-101.CAL edit-20160930_cal.xml EX-101.CAL 35560
9 EX-101.DEF edit-20160930_def.xml EX-101.DEF 173854
10 EX-101.LAB edit-20160930_lab.xml EX-101.LAB 423995
11 EX-101.PRE edit-20160930_pre.xml EX-101.PRE 278634
Mailing Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142
Business Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 161984288
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences